成都欧林生物科技股份有限公司关于发行境外上市股份（H股）备案申请材料获中国证监会接收的公告

Group 1 - The company, Chengdu Olin Biotechnology Co., Ltd., submitted an application for the issuance of overseas listed shares (H shares) to the Hong Kong Stock Exchange on November 25, 2025 [1] - The application materials for the overseas public offering and listing have been accepted by the China Securities Regulatory Commission (CSRC) [1][2] - The company will comply with relevant regulations and fulfill information disclosure obligations based on the progress of the issuance and listing [2]